These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 24789530)

  • 41. Repeatability of peripapillary retinal nerve fiber layer and inner retinal thickness among two spectral domain optical coherence tomography devices.
    Matlach J; Wagner M; Malzahn U; Göbel W
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6536-46. PubMed ID: 25228545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Papillomacular bundle and inner retinal thicknesses correlate with visual acuity in nonarteritic anterior ischemic optic neuropathy.
    Rebolleda G; Sánchez-Sánchez C; González-López JJ; Contreras I; Muñoz-Negrete FJ
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):682-92. PubMed ID: 25587057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Retinal atrophy using optical coherence tomography (OCT) in 15 patients with multiple sclerosis and comparison with healthy subjects].
    Jeanjean L; Castelnovo G; Carlander B; Villain M; Mura F; Dupeyron G; Labauge P
    Rev Neurol (Paris); 2008 Nov; 164(11):927-34. PubMed ID: 18808761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inner retinal layer thinning in Parkinson disease.
    Hajee ME; March WF; Lazzaro DR; Wolintz AH; Shrier EM; Glazman S; Bodis-Wollner IG
    Arch Ophthalmol; 2009 Jun; 127(6):737-41. PubMed ID: 19506190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson's disease patients.
    Satue M; Garcia-Martin E; Fuertes I; Otin S; Alarcia R; Herrero R; Bambo MP; Pablo LE; Fernandez FJ
    Eye (Lond); 2013 Apr; 27(4):507-14. PubMed ID: 23429414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retinal vessel diameter obtained by optical coherence tomography is spared in Parkinson's disease.
    Gulmez Sevim D; Unlu M; Sonmez S; Gultekin M; Karaca C; Ozturk Oner A
    Int Ophthalmol; 2019 Apr; 39(4):813-819. PubMed ID: 29492727
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered Outer Retinal Structure, Electrophysiology and Visual Perception in Parkinson's Disease.
    Tran KKN; Lee PY; Finkelstein DI; McKendrick AM; Nguyen BN; Bui BV; Nguyen CTO
    J Parkinsons Dis; 2024; 14(1):167-180. PubMed ID: 38189711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography.
    Ojima Y; Hangai M; Sasahara M; Gotoh N; Inoue R; Yasuno Y; Makita S; Yatagai T; Tsujikawa A; Yoshimura N
    Ophthalmology; 2007 Dec; 114(12):2197-207. PubMed ID: 17507096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease.
    Adam CR; Shrier E; Ding Y; Glazman S; Bodis-Wollner I
    J Neuroophthalmol; 2013 Jun; 33(2):137-42. PubMed ID: 23612240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retinal layers in Parkinson's disease: A meta-analysis of spectral-domain optical coherence tomography studies.
    Chrysou A; Jansonius NM; van Laar T
    Parkinsonism Relat Disord; 2019 Jul; 64():40-49. PubMed ID: 31054866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of retinal alterations in Parkinson disease and tremor diseases.
    Tugcu B; Melikov A; Yildiz GB; Gökcal E; Ercan R; Uysal O; Ozdemir H
    Acta Neurol Belg; 2020 Feb; 120(1):107-113. PubMed ID: 31679150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative analysis of related parameters of retinal nerve fiber layer and ganglion cell complex thickness in patients with different degrees of Parkinson's disease.
    Zhao Y; Dai W; Liu D
    Aging Clin Exp Res; 2022 Oct; 34(10):2355-2361. PubMed ID: 36048412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduced Thickness of the Retina in de novo Parkinson's Disease Shows A Distinct Pattern, Different from Glaucoma.
    Chrysou A; Heikka T; van der Zee S; Boertien JM; Jansonius NM; van Laar T
    J Parkinsons Dis; 2024; 14(3):507-519. PubMed ID: 38517802
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Morphologic photoreceptor abnormality in occult macular dystrophy on spectral-domain optical coherence tomography.
    Park SJ; Woo SJ; Park KH; Hwang JM; Chung H
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3673-9. PubMed ID: 20164460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Photoreceptor layer map using spectral-domain optical coherence tomography.
    Lee JE; Lim DW; Bae HY; Park HJ
    Optom Vis Sci; 2009 Dec; 86(12):E1320-7. PubMed ID: 19844189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of retinal manifestations of Parkinson's disease using spectral domain optical coherence tomography: A study in Indian eyes.
    Verghese S; Berkowitz ST; Shah VM; Shah P; Priya S; Saravanan VR; Narendran V; Selvan VA
    Indian J Ophthalmol; 2022 Feb; 70(2):448-452. PubMed ID: 35086214
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
    Zaveri MS; Conger A; Salter A; Frohman TC; Galetta SL; Markowitz CE; Jacobs DA; Cutter GR; Ying GS; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
    Arch Neurol; 2008 Jul; 65(7):924-8. PubMed ID: 18625859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of levodopa on retina in Parkinson disease.
    Sen A; Tugcu B; Coskun C; Ekinci C; Nacaroglu SA
    Eur J Ophthalmol; 2014; 24(1):114-9. PubMed ID: 23828323
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the retinal changes in patients with chronic migraine.
    Kirbas S; Tufekci A; Turkyilmaz K; Kirbas A; Oner V; Durmus M
    Acta Neurol Belg; 2013 Jun; 113(2):167-72. PubMed ID: 23135780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Applications of visual evoked potentials and Fourier-domain optical coherence tomography in Parkinson's disease: a controlled study.
    Quagliato LB; Domingues C; Quagliato EM; Abreu EB; Kara-Junior N
    Arq Bras Oftalmol; 2014 Aug; 77(4):238-42. PubMed ID: 25410176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.